Literature DB >> 517608

Ischemic optic neuropathy as a possible early complication of vascular hypertension.

C Ellenberger.   

Abstract

Eighteen patients with idiopathic optic neuropathy lacked symptoms and signs of cardiovascular and cerebrovascular disease, especially when compared to three groups of patients with sudden visual loss caused by retinal infarction, transient ischemia, and cerebral infarction. Many patients in the latter groups had hypertension, carotid bruits, heart disease, transient ischemic attack, and stroke. But among the patients with ischemic optic neuropathy, hypertension was the only evidence of cardiovascular disease, affecting 44% of the patients. We argue that, in many cases, ischemic optic neuropathy represents a direct and early complication of hypertension arterial disease affecting small arterioles supplying the anterior part of the optic nerve. The pathologic process may thus be similar or identical to lacunar infarction of the brain.

Entities:  

Mesh:

Year:  1979        PMID: 517608     DOI: 10.1016/0002-9394(79)90414-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Anterior ischemic optic neuropathy: sense and nonsense in diagnosis and treatment.

Authors:  L A Bastiaensen; R W Keunen; C C Tijssen; J J Vandoninck
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

2.  Anterior ischaemic optic neuropathy: recurrent episodes in the same eye.

Authors:  R W Beck; P J Savino; N J Schatz; C H Smith; R Sergott
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

3.  Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders.

Authors:  S S Hayreh
Journal:  Doc Ophthalmol       Date:  1985-04-30       Impact factor: 2.379

Review 4.  The management of acute visual failure.

Authors:  S H Wray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.